Wei Xiao
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Biological Psychiatry top 5%
Papers in
-
- Plant and Fungal Species Descriptions 12
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 15
- Co-authors
- Wei Liu (2 shared papers)Yan Deng (1 shared paper)Huiguo Liu (2 shared papers)Ying-Nan Wang (1 shared paper)Kui Liu (1 shared paper)Meifang Wang (1 shared paper)Zhenzhong Wang (23 shared papers)John D. Klement (6 shared papers)
- Journals
- Medicine (12 papers)International Journal of COPD (8 papers)Oncology Reports (7 papers)Frontiers in Pharmacology (6 papers)Frontiers in Oncology (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Xiao
460 papers receiving 8.2k citations
Wei Xiao's Hit Papers
Peers
Comparison fields: 5 of 176
- Infectious Diseases 938
- Biological Psychiatry 118
- Immunology 978
- Cancer Research 603
- Neurology 557
Countries citing papers authored by Wei Xiao
This map shows the geographic impact of Wei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xiao more than expected).
Fields of papers citing papers by Wei Xiao
This network shows the impact of papers produced by Wei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xiao. The network helps show where Wei Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 479 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Hit paper breakdown → | 2020 | 1045 |
| 2 | 2017 | 169 | |
| 3 | 2017 | 137 | |
| 4 | 2017 | 132 | |
| 5 | 2015 | 129 | |
| 6 | 2014 | 98 | |
| 7 | 2019 | 97 | |
| 8 | 2015 | 92 | |
| 9 | 2020 | 87 | |
| 10 | 2019 | 84 | |
| 11 | 2017 | 84 | |
| 12 | 2018 | 78 | |
| 13 | 2018 | 77 | |
| 14 | 2017 | 70 | |
| 15 | 2018 | 69 | |
| 16 | 2009 | 68 | |
| 17 | 2016 | 65 | |
| 18 | 2014 | 65 | |
| 19 | 2019 | 65 | |
| 20 | 2020 | 64 |
About Wei Xiao
Wei Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Oncology, having authored 479 papers that have together received 8.3k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Plant and Fungal Species Descriptions (12 papers), Genetic diversity and population structure (12 papers), Cancer-related molecular mechanisms research (10 papers), Traditional Chinese Medicine Analysis (10 papers), Pharmacological Effects of Natural Compounds (10 papers), Immune Cell Function and Interaction (9 papers) and Plant-based Medicinal Research (8 papers). The work is most often cited by research in Infectious Diseases (938 citations), Biological Psychiatry (118 citations), Immunology (978 citations), Cancer Research (603 citations) and Neurology (557 citations). Wei Xiao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei Liu, Yan Deng, Huiguo Liu, Ying-Nan Wang, Kui Liu, Meifang Wang, Zhenzhong Wang, John D. Klement, Zhiyong Gao and Kebin Liu. Their work appears in journals such as Medicine, International Journal of COPD, Oncology Reports, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.